QTX3034 in Patients With KRAS G12D Mutation
Conditions
Solid Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCLA Hematology/Oncology, Los Angeles, California, United States
Sarah Cannon Research Institute (SCRI), Denver, Colorado, United States
Yale Cancer Center, New Haven, Connecticut, United States
Florida Cancer Specialists, Sarasota, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
NYU Langone Health, New York, New York, United States
Montefiore Medical Center, The Bronx, New York, United States
Duke University, Durham, North Carolina, United States
Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
SCRI- Nashville, Nashville, Tennessee, United States
MD Anderson, Houston, Texas, United States
START San Antonio, LLC, San Antonio, Texas, United States
Contact: Study coordinator (Isabel Jimenez, RN, MSN) · isabel.jimenez@startresearch.com · 210-593-5265University of Utah, Huntsman Cancer Center, Salt Lake City, Utah, United States
NEXT Oncology Virginia, Fairfax, Virginia, United States